• China’s Antengene raises $120m to boost drug development pharmaceutical-technology
    January 03, 2019
    Chinese biopharmaceutical firm Antengene has raised $120m in a series B funding round led by Boyu Capital and FountainVest to support the development and commercialisation of new therapeutics.....
PharmaSources Customer Service